These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 17134770

  • 1. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
    Marazzi G, Wajngarten M, Vitale C, Patrizi R, Pelliccia F, Gebara O, Pierri H, Ramires JA, Volterrani M, Fini M, Rosano GM.
    Int J Cardiol; 2007 Aug 09; 120(1):79-84. PubMed ID: 17134770
    [Abstract] [Full Text] [Related]

  • 2. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
    Fragasso G, Piatti Md PM, Monti L, Palloshi A, Setola E, Puccetti P, Calori G, Lopaschuk GD, Margonato A.
    Am Heart J; 2003 Nov 09; 146(5):E18. PubMed ID: 14597947
    [Abstract] [Full Text] [Related]

  • 3. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R, Cianci G, Gigli M, Mazzanti M, Lacalaprice F.
    J Cardiovasc Pharmacol; 2008 Jun 09; 51(6):611-5. PubMed ID: 18574390
    [Abstract] [Full Text] [Related]

  • 4. Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease.
    Rosano GM, Marazzi G, Patrizi R, Cerquetani E, Vitale C, Volterrani M, Fini M, Mercuro G.
    Am J Cardiol; 2005 Feb 01; 95(3):327-31. PubMed ID: 15670539
    [Abstract] [Full Text] [Related]

  • 5. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
    Rosano GM, Vitale C, Fragasso G.
    Am J Cardiol; 2006 Sep 04; 98(5A):14J-18J. PubMed ID: 16931201
    [Abstract] [Full Text] [Related]

  • 6. The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow.
    Topal E, Ozdemir R, Barutcu I, Aksoy Y, Sincer I, Akturk E, Cehreli S.
    J Electrocardiol; 2006 Apr 04; 39(2):211-8. PubMed ID: 16580422
    [Abstract] [Full Text] [Related]

  • 7. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G, Gebara O, Vitale C, Caminiti G, Wajngarten M, Volterrani M, Ramires JA, Rosano G, Fini M.
    Adv Ther; 2009 Apr 04; 26(4):455-61. PubMed ID: 19396409
    [Abstract] [Full Text] [Related]

  • 8. Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study.
    Rosano GM, Vitale C, Sposato B, Mercuro G, Fini M.
    Cardiovasc Diabetol; 2003 Nov 28; 2():16. PubMed ID: 14641923
    [Abstract] [Full Text] [Related]

  • 9. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C, Wajngaten M, Sposato B, Gebara O, Rossini P, Fini M, Volterrani M, Rosano GM.
    Eur Heart J; 2004 Oct 28; 25(20):1814-21. PubMed ID: 15474696
    [Abstract] [Full Text] [Related]

  • 10. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct 28; 15(5):533-40. PubMed ID: 18797405
    [Abstract] [Full Text] [Related]

  • 11. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
    Di Napoli P, Di Giovanni P, Gaeta MA, D'Apolito G, Barsotti A.
    Am Heart J; 2007 Sep 28; 154(3):602.e1-5. PubMed ID: 17719313
    [Abstract] [Full Text] [Related]

  • 12. Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy.
    Monti LD, Setola E, Fragasso G, Camisasca RP, Lucotti P, Galluccio E, Origgi A, Margonato A, Piatti P.
    Am J Physiol Endocrinol Metab; 2006 Jan 28; 290(1):E54-E59. PubMed ID: 16174656
    [Abstract] [Full Text] [Related]

  • 13. Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project--Free Radicals.
    Eur Heart J; 2000 Sep 28; 21(18):1537-46. PubMed ID: 10973768
    [Abstract] [Full Text] [Related]

  • 14. Does gastro-esophageal reflux provoke the myocardial ischemia in patients with CAD?
    Dobrzycki S, Baniukiewicz A, Korecki J, Bachórzewska-Gajewska H, Prokopczuk P, Musial WJ, Kamiński KA, Dabrowski A.
    Int J Cardiol; 2005 Sep 15; 104(1):67-72. PubMed ID: 16137512
    [Abstract] [Full Text] [Related]

  • 15. Trimetazidine added to combined hemodynamic antianginal therapy in patients with type 2 diabetes: a randomized crossover trial.
    Ribeiro LW, Ribeiro JP, Stein R, Leitão C, Polanczyk CA.
    Am Heart J; 2007 Jul 15; 154(1):78.e1-7. PubMed ID: 17584555
    [Abstract] [Full Text] [Related]

  • 16. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts.
    Onay-Besikci A, Guner S, Arioglu E, Ozakca I, Ozcelikay AT, Altan VM.
    Can J Physiol Pharmacol; 2007 May 15; 85(5):527-35. PubMed ID: 17632588
    [Abstract] [Full Text] [Related]

  • 17. Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.
    Leonardo F, Fragasso G, Rossetti E, Dabrowski P, Pagnotta P, Rosano GM, Chierchia SL.
    Cardiologia; 1999 Dec 15; 44(12):1065-9. PubMed ID: 10687257
    [Abstract] [Full Text] [Related]

  • 18. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
    Jaumdally RJ, Lip GY, Patel JV, MacFadyen RJ, Varma C.
    J Intern Med; 2009 Jun 15; 265(6):689-97. PubMed ID: 19226374
    [Abstract] [Full Text] [Related]

  • 19. Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine.
    Fragasso G, Piatti PM, Monti L, Palloshi A, Lu C, Valsecchi G, Setola E, Calori G, Pozza G, Margonato A, Chierchia S.
    J Am Coll Cardiol; 2002 Feb 06; 39(3):413-9. PubMed ID: 11823078
    [Abstract] [Full Text] [Related]

  • 20. The anti-ischemic effect of trimetazidine in patients with postprandial myocardial ischemia is unrelated to meal composition.
    Fragasso G, Montano C, Perseghin G, Palloshi A, Calori G, Lattuada G, Oggionni S, Bassanelli G, Locatelli M, Lopaschuk G, Margonato A.
    Am Heart J; 2006 Jun 06; 151(6):1238.e1-8. PubMed ID: 16781225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.